Valuation: PHARMING GROUP

Market Cap 891M 810M 748M 676M 1.28B 83.68B 1.32B 9B 3.56B 44.9B 3.34B 3.27B 142B P/E 2026 *
41x
P/E 2027 * 33.4x
Enterprise Value 836M 760M 702M 634M 1.2B 78.54B 1.24B 8.44B 3.35B 42.15B 3.14B 3.07B 134B EV / Sales 2026 *
2.16x
EV / Sales 2027 * 1.84x
Free-Float
98.98%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 58 28/09/2026
Chief Executive Officer - 28/09/2026
Chief Tech/Sci/R&D Officer 54 31/05/2021
Director TitleAgeSince
Director/Board Member 71 10/12/2020
Director/Board Member 62 10/12/2020
Director/Board Member 60 18/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+2.56%+41.74%+145.97% 1,286B
-0.25%+0.88%+42.60%+89.61% 688B
+0.74%+1.20%+26.84%+114.64% 521B
+1.14%+2.04%+42.51%+72.81% 386B
-0.62%-1.43%+57.90%+43.77% 364B
+1.27%+1.72%+28.34%+63.11% 302B
+0.37%-0.23%+3.25%+38.05% 287B
+0.66%+0.78%+37.21%+74.30% 252B
+0.98%+0.08%+36.55%+127.39% 208B
Average +0.42%+2.08%+35.22%+85.52% 477B
Weighted average by Cap. +0.34%+3.26%+37.48%+99.76%

Financials

2026 *2027 *
Net sales 387M 352M 325M 294M 554M 36.37B 574M 3.91B 1.55B 19.52B 1.45B 1.42B 61.82B 422M 383M 354M 320M 604M 39.63B 625M 4.26B 1.69B 21.26B 1.58B 1.55B 67.36B
Net income 26.77M 24.32M 22.47M 20.3M 38.31M 2.51B 39.65M 270M 107M 1.35B 100M 98.33M 4.27B 28.8M 26.17M 24.18M 21.84M 41.21M 2.7B 42.66M 291M 115M 1.45B 108M 106M 4.6B
Net Debt -54.72M -49.71M -45.93M -41.49M -78.29M -5.14B -81.05M -552M -219M -2.76B -205M -201M -8.73B -115M -105M -96.65M -87.3M -165M -10.81B -171M -1.16B -461M -5.8B -432M -423M -18.38B
Logo PHARMING GROUP
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The group is developing and commercializing a portfolio of innovative medicines, including small molecules and biologics.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - PHARMING GROUP